We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
-6.42%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$3.29B
AUM Growth
+$73M
Cap. Flow
+$288M
Cap. Flow %
8.77%
Top 10 Hldgs %
33.54%
Holding
352
New
136
Increased
52
Reduced
76
Closed
78

Top Buys

Rank Stock Value
1
LIVN icon
LivaNova
LIVN
+$42.5M
2
MAPS
WM TECHNOLOGY INC A
MAPS
+$23.3M
3
SEER icon
Seer Inc
SEER
+$20.8M
4
GKOS icon
Glaukos
GKOS
+$17.9M
5
COO icon
Cooper Companies
COO
+$17.1M

Top Sells

Rank Stock Value
1
INOV
Inovalon Holdings, Inc. Class A Common Stock
INOV
+$60.7M
2
NTLA icon
Intellia Therapeutics
NTLA
+$26.2M
3
ORGO icon
Organogenesis Holdings
ORGO
+$19.9M
4
LLY icon
Eli Lilly
LLY
+$15.1M
5
CMIIU
CM Life Sciences II Inc. Unit
CMIIU
+$14.1M

Sector Composition

Rank Sector Weight
1 Healthcare 33.25%
2 Consumer Staples 0.8%
3 Technology 0.71%
4 Industrials 0.71%
5 Materials 0.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACHV icon
276
Achieve Life Sciences
ACHV
$687M
– –
-17,000
Closed -$153K
AKYA
277
DELISTED
Akoya BioSciences
AKYA
– –
-239,566
Closed -$4.63M
ALT icon
278
CALL
Altimmune
ALT
$570M
– –
-97,500
Closed -$960K
ARVN icon
279
Arvinas
ARVN
$580M
– –
-31,543
Closed -$2.43M
AVDL
280
DELISTED
Avadel Pharmaceuticals
AVDL
– –
-176,206
Closed -$1.39M
CGEN icon
281
CALL
Compugen
CGEN
$236M
– –
-248,800
Closed -$2.06M
CGEN icon
282
PUT
Compugen
CGEN
$236M
– –
-194,900
Closed -$1.61M
CLOV icon
283
PUT
Clover Health Investments
CLOV
$2.41B
– –
-500,000
Closed -$6.66M
CMPS
284
Compass Pathways
CMPS
$1.97B
– –
-190,071
Closed -$6.38M
CORT icon
285
CALL
Corcept Therapeutics
CORT
$12.1B
– –
-200,000
Closed -$4.4M
CRBP icon
286
CALL
Corbus Pharmaceuticals
CRBP
$189M
– –
-56,760
Closed -$3.12M
CVAC
287
CALL
DELISTED
CureVac
CVAC
– –
-132,300
Closed -$9.72M
CVRX icon
288
CVRx
CVRX
$72.7M
– –
-250,000
Closed -$7M
DGX icon
289
PUT
Quest Diagnostics
DGX
$26.2B
– –
-50,000
Closed -$6.6M
DOCS icon
290
Doximity
DOCS
$4.45B
– –
-50,000
Closed -$2.91M
EPIX
291
DELISTED
ESSA Pharma
EPIX
– –
-38,803
Closed -$1.11M
ESTA icon
292
CALL
Establishment Labs
ESTA
$2.25B
– –
-48,800
Closed -$4.26M
EXEL icon
293
Exelixis
EXEL
$12.5B
– –
-51,779
Closed -$943K
FBRX icon
294
Forte Biosciences
FBRX
$1.57B
– –
-2,623
Closed -$2.21M
KYNB
295
CALL
Kyntra Bio
KYNB
$28.7M
– –
-7,804
Closed -$5.2M
KYNB
296
PUT
Kyntra Bio
KYNB
$28.7M
– –
-8,520
Closed -$5.67M
GKOS icon
297
PUT
Glaukos
GKOS
$11B
– –
-40,000
Closed -$3.39M
GLUE icon
298
Monte Rosa Therapeutics
GLUE
$1.36B
– –
-100,000
Closed -$2.27M
HCA icon
299
PUT
HCA Healthcare
HCA
$89.8B
– –
-185,000
Closed -$38.2M
ICAD
300
DELISTED
iCAD Inc
ICAD
– –
-310,278
Closed -$5.37M
10 11
12
13 14

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q3 2021 Portfolio in Review

As of Q3 2021, Pura Vida Investments held 352 positions worth $3.29B, up 2.3% from $3.21B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Pura Vida Investments deployed $288M of net new capital in Q3 2021, opening 136 new positions and adding to 52 existing holdings. Its largest new stake was WM TECHNOLOGY INC A: 1,612,498 shares worth $23.4M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 35% a quarter earlier, followed by Consumer Staples and Technology.

On the sell side, the largest reduction was Intellia Therapeutics, an estimated $26.2M trimmed.

  • Pura Vida Investments's largest Q3 2021 buy was WM TECHNOLOGY INC A: 1,612,498 shares worth $23.4M.
  • Pura Vida Investments added most to LivaNova in Q3 2021, an estimated $42.5M increase.
  • Pura Vida Investments's biggest Q3 2021 reduction was Intellia Therapeutics, cutting an estimated $26.2M.
  • Pura Vida Investments fully exited Inovalon Holdings, Inc. Class A Common Stock in Q3 2021, selling an estimated $60.7M.
  • Pura Vida Investments's ten largest holdings make up 34% of its $3.29B portfolio in Q3 2021.
  • Pura Vida Investments opened 136 new positions and closed 78 in Q3 2021.
  • Pura Vida Investments's portfolio value rose 2.3% quarter-over-quarter to $3.29B.

Based on Pura Vida Investments's 13F filing for Q3 2021, filed 15 Nov 2021.